Novel fluticasone, orally disintegrating tablet well tolerated in EoE

APT-1011, a novel fluticasone orally disintegrating tablet, effectively induced histologic response, improved symptoms and decreased endoscopic severity, according to a presentation at the American College of Gastroenterology Virtual Annual Meeting.“Histologic response was maintained through week 52, as were improvements in the number of dysphagia episodes, Global EoE Symptom Scores and [Eosinophilic Esophagitis Endoscopy Reference Score (EREFS)],” Evan S. Dellon, MD, MPH, from the Center for Esophageal Diseases and Swallowing, division of gastroenterology and hepatology at theRead More

Share on facebook
Share on twitter
Share on linkedin